Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Alexis Krumme, ScD (she/her/hers)
Associate Director
Johnson & Johnson, Titusville, New Jersey, USA
Poster(s):
(292) Prediction of Hemolytic Disease of the Fetus and Newborn in neonates from alloimmunized pregnancies
Tuesday, August 27, 2024
8:00 AM – 6:00 PM
CEST
(296) Pregnancy and infant outcomes in gestationally-diagnosed breast cancer: A pilot study in Finland and Norway from the IMI ConcePTION project
Tuesday, August 27, 2024
8:00 AM – 6:00 PM
CEST
(CSPOT17) A post-authorization safety study of golimumab in ulcerative colitis using the Spanish ENEIDA registry (MK8259-042)
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
